Ding D[au] - Search Results

Year	Number of Results
1972	1
1976	1
1979	1
1980	2
1982	5
1983	1
1984	4
1985	1
1986	1
1987	3
1989	1
1990	7
1991	4
1992	4
1993	11
1994	14
1995	5
1996	10
1997	15
1998	19
1999	25
2000	36
2001	22
2002	18
2003	28
2004	29
2005	31
2006	27
2007	38
2008	45
2009	63
2010	69
2011	100
2012	105
2013	172
2014	268
2015	251
2016	231
2017	274
2018	288
2019	313
2020	354
2021	398
2022	247

1

Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis.

Ironside N, Nguyen C, Do Q, Ugiliweneza B, Chen CJ, Sieg EP, James RF, Ding D. Ironside N, et al. Among authors: ding d. J Neurointerv Surg. 2021 Oct;13(10):951-957. doi: 10.1136/neurintsurg-2021-017352. Epub 2021 Jun 30. J Neurointerv Surg. 2021. PMID: 34193592 Review.

2

Epilepsy in China: major progress in the past two decades.

Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Ding D, et al. Lancet Neurol. 2021 Apr;20(4):316-326. doi: 10.1016/S1474-4422(21)00023-5. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743240 Review.

3

Physical activity behaviours in adolescence: current evidence and opportunities for intervention.

van Sluijs EMF, Ekelund U, Crochemore-Silva I, Guthold R, Ha A, Lubans D, Oyeyemi AL, Ding D, Katzmarzyk PT. van Sluijs EMF, et al. Among authors: ding d. Lancet. 2021 Jul 31;398(10298):429-442. doi: 10.1016/S0140-6736(21)01259-9. Epub 2021 Jul 21. Lancet. 2021. PMID: 34302767 Free PMC article. Review.

4

A donor-DNA-free CRISPR/Cas-based approach to gene knock-up in rice.

Lu Y, Wang J, Chen B, Mo S, Lian L, Luo Y, Ding D, Ding Y, Cao Q, Li Y, Li Y, Liu G, Hou Q, Cheng T, Wei J, Zhang Y, Chen G, Song C, Hu Q, Sun S, Fan G, Wang Y, Liu Z, Song B, Zhu JK, Li H, Jiang L. Lu Y, et al. Among authors: ding d. Nat Plants. 2021 Nov;7(11):1445-1452. doi: 10.1038/s41477-021-01019-4. Epub 2021 Nov 15. Nat Plants. 2021. PMID: 34782773

5

ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.

Wang D, Ma J, Botuyan MV, Cui G, Yan Y, Ding D, Zhou Y, Krueger EW, Pei J, Wu X, Wang L, Pei H, McNiven MA, Ye D, Mer G, Huang H. Wang D, et al. Among authors: ding d. Sci Adv. 2021 Jun 18;7(25):eabd9208. doi: 10.1126/sciadv.abd9208. Print 2021 Jun. Sci Adv. 2021. PMID: 34144977 Free PMC article.

6

Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells.

Ma L, Diao L, Peng Z, Jia Y, Xie H, Li B, Ma J, Zhang M, Cheng L, Ding D, Zhang X, Chen H, Mo F, Jiang H, Xu G, Meng F, Zhong Z, Liu M. Ma L, et al. Among authors: ding d. Adv Mater. 2021 Oct;33(43):e2104849. doi: 10.1002/adma.202104849. Epub 2021 Sep 18. Adv Mater. 2021. PMID: 34536044

7

Hsa_circ_0007534 knockdown represses the development of colorectal cancer cells through regulating miR-613/SLC25A22 axis.

Ding DY, Wang D, Shu ZB. Ding DY, et al. Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):570. doi: 10.26355/eurrev_202101_24605. Eur Rev Med Pharmacol Sci. 2021. PMID: 33577003 Free article.

8

HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer.

Zhou Y, Jin X, Ma J, Ding D, Huang Z, Sheng H, Yan Y, Pan Y, Wei T, Wang L, Wu H, Huang H. Zhou Y, et al. Among authors: ding d. Cancer Res. 2021 Mar 15;81(6):1486-1499. doi: 10.1158/0008-5472.CAN-20-2828. Epub 2021 Jan 8. Cancer Res. 2021. PMID: 33419772

9

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.

Loomba R, Noureddin M, Kowdley KV, Kohli A, Sheikh A, Neff G, Bhandari BR, Gunn N, Caldwell SH, Goodman Z, Wapinski I, Resnick M, Beck AH, Ding D, Jia C, Chuang JC, Huss RS, Chung C, Subramanian GM, Myers RP, Patel K, Borg BB, Ghalib R, Kabler H, Poulos J, Younes Z, Elkhashab M, Hassanein T, Iyer R, Ruane P, Shiffman ML, Strasser S, Wong VW, Alkhouri N; ATLAS Investigators. Loomba R, et al. Among authors: ding d. Hepatology. 2021 Feb;73(2):625-643. doi: 10.1002/hep.31622. Hepatology. 2021. PMID: 33169409 Clinical Trial.

10

Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG.

Shao J, Yan Y, Ding D, Wang D, He Y, Pan Y, Yan W, Kharbanda A, Li HY, Huang H. Shao J, et al. Among authors: ding d. Adv Sci (Weinh). 2021 Oct;8(20):e2102555. doi: 10.1002/advs.202102555. Epub 2021 Aug 16. Adv Sci (Weinh). 2021. PMID: 34397171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results